KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt repayments

Daily Values

Growth Metrics

LifeMD (LFMD) Shares Issued (2016 - 2025)

LifeMD filings provide 11 years of Shares Issued readings, the most recent being $8.7 million for Q3 2025.

On a quarterly basis, Shares Issued changed N/A to $8.7 million in Q3 2025 year-over-year; TTM through Dec 2025 was $8.7 million, a 7141.59% increase, with the full-year FY2025 number at $464950.0, up 286.45% from a year prior.
Shares Issued hit $8.7 million in Q3 2025 for LifeMD, up from $12499.0 in the prior quarter.
In the past five years, Shares Issued ranged from a high of $13.5 million in Q1 2021 to a low of -$51900.0 in Q4 2022.
Median Shares Issued over the past 5 years was $75950.0 (2022), compared with a mean of $2.8 million.
Biggest five-year swings in Shares Issued: plummeted 127.3% in 2022 and later surged 10317.9% in 2023.
LifeMD's Shares Issued stood at $190141.0 in 2021, then plummeted by 127.3% to -$51900.0 in 2022, then surged by 10317.9% to $5.3 million in 2023, then crashed by 99.76% to $12499.0 in 2024, then skyrocketed by 69505.57% to $8.7 million in 2025.
The last three reported values for Shares Issued were $8.7 million (Q3 2025), $12499.0 (Q4 2024), and $100000.0 (Q2 2024) per Business Quant data.